Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: FEBS Lett. 2013 Sep 13;587(21):3456–3463. doi: 10.1016/j.febslet.2013.08.034

Figure 5. MPs from CHD patients interact abnormally with recombinant Del-1 protein.

Figure 5

A) Binding of recombinant Del-1 to MPs from healthy subjects and patients with significant CHD. MPs from healthy subjects or CHD patients were incubated with increasing concentrations of recombinant Del-1 protein then stained with FITC-labeled annexin V; representative flow cytometry histograms are shown. B) Binding efficiency of recombinant Del-1 to MPs from healthy subjects and patients with CHD. The slope of the linear region of the Del-1 binding curve (showing the 95% CI) estimates the efficiency of Del-1 binding to PS on MPs. (n = 10 for each group in panel A; n = 12 for each group in panel B (pooled samples). #p < 0.05 (Student t test).